ERBB2 and neoplasm: Despite the important role of miR-21-mediated PTEN and PDCD4 deficiency in drug resistance, the response to anti-HER2 and chemotherapeutic agents may be dependent on additional mechanisms, including the boosting of a local inflammatory signaling, which is responsible for the release of specific cytokines and the expansion of tumor cells with an EMT phenotype [13, 18, 28].